(Press-News.org) Two new papers from the lab of Zach Schafer, Coleman Assistant Professor of Cancer Biology at the University of Notre Dame, offer insights into how breast cancer cells avoid anoikis, which is cell death induced by detachment from the extracellular matrix (ECM).
"Metastasis, the spread of cancer cells from the primary tumor site to distant sites in the body, is responsible for in excess of 90 percent of cancer deaths," Schafer said. "In order for cancer cells to metastasize, they must survive the trip from the primary tumor to a secondary site. A significant barrier to cancer cell survival is the process of anoikis. Cancer cells are periodically exposed to ECM detachment during metastasis, and thus it is critically important to better understand at the molecular level how cancer cells block anoikis. If we could better understand these molecular mechanisms, we could design novel chemotherapeutics aimed at inducing anoikis and thereby blocking metastasis."
The research described in the first paper describes how Schafer's lab group discovered that ErbB2, an oncogene overexpressed in approximately 30 percent of breast cancer patients, can block the induction of anoikis by causing multicellular aggregation. This multicellular aggregation results in stabilization of another protein, EGFR, that can signal in ECM-detached breast cancer cells to block anoikis.
"These findings suggest that finding ways to break up multicellular aggregates might be an effective strategy to eliminate metastasizing breast cancer cells," Schafer said. "In addition, targeting the EGFR protein has not been particularly effective in breast cancer patients, but our studies suggest that this may be a useful strategy to eliminate ECM-detached cancer cells."
The research was led by Raju Rayavarapu, a doctoral candidate in the Department of Biological Sciences under Schafer's supervision. Melissa Shaw, a junior biological sciences major, was a contributing author, and two former Notre Dame undergraduates, Brendan Heiden and Nicholas Pagani, also were co-authors. Additionally, Sydney Shuff, a high school senior at Concord High School in Elkhart, was a co-author and Siyuan Zhang, Nancy Dee Assistant Professor of Cancer Research at the Harper Cancer Research Institute, collaborated on the work.
The paper was featured as the cover article of the Journal of Biological Chemistry and can be accessed here. Kimbra Turner, a doctoral student in biological sciences at Notre Dame, designed the cover art.
The second paper focused on understanding anoikis inhibition in inflammatory breast cancer, a rare subtype of breast cancer.
"Inflammatory breast cancer (IBC) has a very unique disease progression that causes women to be frequently misdiagnosed," Schafer said. "Instead of starting as a lump in the breast, IBC manifests as reddened skin that is often mistaken for an infection. In fact, this reddening is due to IBC cancer cells lodging in the lymphatic vessels under the skin. It is inherently aggressive and the fact that it is frequently misdiagnosed exacerbates problems for the patient. Prognosis for women with IBC is often poor."
In this study, the researchers discovered a unique molecular mechanism used by IBC cells to block anoikis.
"Unlike what we observed in other breast cancer cells, we have found that IBC cells have elevated levels of the protein Bim-EL," Schafer said. "This protein typically would either be eliminated rapidly or, conversely, localized in the cell to cause cell death. However, in IBC cells, this protein binds to two other proteins (Beclin-1 and LC8) in a fashion that prevents it from causing cell death. This appears to be a unique mechanism utilized by IBC cells to block anoikis."
The fact that Bim-EL, a protein that can cause cells to die, is present in high levels in IBC cells represents an attractive therapeutic target. Approaches aimed at freeing Bim-EL from the complex with Beclin-1 and LC8 may be effective in specifically eliminating IBC cells.
INFORMATION:
The research in Schafer's lab was led by Cassandra Buchheit, a recent graduate of the Notre Dame's doctoral program in biological sciences. Kelsey Weigel, a doctoral candidate in biological sciences, and former undergraduate students Brittany Angarola and Allison Steiner were also co-authors on the manuscript. The research effort was initiated due to support from Notre Dame's Boler-Parseghian Center for Rare and Neglected Diseases.
The paper appeared in the journal Cell Death and Differentiation.
In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a University of Colorado Cancer Center study shows that orally administering the chemical silibinin, purified from milk thistle, slows the ability of colorectal cancer stem cells to grow the disease. When stem cells from tumors grown in silibinin-fed conditions were re-injected into new models, the cells failed to develop equally aggressive tumors even in the absence of silibinin.
"It's very simple: tumors from mice that were initially fed silibinin had fewer cancer stem cells, ...
Researchers from The University of Manchester working with drug development company Evgen Pharma, have developed a new combination of drugs which could overcome treatment resistance and relapse in breast cancer.
In research to be revealed at the American Association of Cancer Research annual conference on Monday, the researchers show that in the most common type of breast cancer, affecting 70% of patients, the drug Sulforadex helps overcome resistance to routinely used hormonal treatments by targeting the cancer stem cell population.
While most women initially respond ...
HANOVER, N.H. - Dartmouth astrophysicists and their colleagues have not only proven that a supermassive black hole exists in a place where it isn't supposed to be, but in doing so have opened a new door to what things were like in the early universe.
Henize 2-10 is a small irregular galaxy that is not too far away in astronomical terms -- 30 million light-years. "This is a dwarf starburst galaxy -- a small galaxy with regions of very rapid star formation -- about 10 percent of the size of our own Milky Way," says co-author Ryan Hickox, an assistant professor in Dartmouth's ...
A new review of the ideas and work of Patrick Matthew, a little-known antecedent of Charles Darwin, argues that Matthew is under-appreciated even though he described the idea of large-scale evolution by natural selection decades before Darwin did. Some of his ideas were different from Darwin's but are equally valid.
"Patrick Matthew was a fascinating character--strong-willed and fiercely independent," said Dr. Michael Weale, author of the Biological Journal of the Linnean Society article. "Darwin used detailed, methodical force of argument to convince the world of evolution ...
For many students or junior academics--and even for senior investigators--initiating a new piece of research can be a daunting experience, and they often do not know where or how to begin. A recent Accounting and Finance article offers a simple new research tool that can act as a template designed for pitching research ideas to mentors or other experts.
The two-page pitching template includes 4 preliminary components: working title, research question, key papers, and motivation. Next is a '3-2-1 countdown' that is based on 3 elements - idea, data, and tools; 2 questions ...
Among soft-bodied cephalopods, vampire squid live life at a slower pace. At ocean depths from 500 to 3,000 meters, they don't swim so much as float, and they get by with little oxygen while consuming a low-calorie diet of zooplankton and detritus. Now, researchers reporting in the Cell Press journal Current Biology on April 20 have found that vampire squid differ from all other living coleoid cephalopods in their reproductive strategy as well.
While other squid reproduce all at once late in their lives, vampire squid appear to alternate between reproductive and resting ...
Household pets can transmit infection to people, especially those with weak immune systems, young children, pregnant women and seniors, according to an article in CMAJ (Canadian Medical Association Journal). Health care providers and pet owners should be aware of this risk to prevent illness in vulnerable people.
Surveys suggest that the general public and people at high risk for pet-associated disease are not aware of the risks associated with high-risk pet practices or recommendations to reduce them; for example, 77% of households that obtained a new pet following a ...
La Jolla, Calif., April 20, 2015 - A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47. E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease each year in the United States.
"For the first time, we have shown that overexpression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram ...
COLUMBUS, Ohio--As new medical diagnostics become available, researchers are increasingly discovering situations in which pets can transmit diseases to humans--especially when an owner's immune system is compromised.
At The Ohio State University and partner institutions, researchers have compiled the latest information from more than 500 studies worldwide to make recommendations on how families can minimize the risk of disease transmission by choosing the right type of pet, or by making small changes in how they enjoy the pets they already have.
The review was published ...
A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at the Ruhrlandklinik in Essen. It is an automatable imaging process which, by classifying specific forms of lung cancer, facilitates a prognosis regarding a tumour's aggressiveness. The team, headed by RUB Prof Dr Klaus Gerwert, compares the results of traditional diagnostic procedures ...
